BMS-903452
CAS No. 1339944-47-6
BMS-903452( —— )
Catalog No. M35988 CAS No. 1339944-47-6
BMS-903452 is a potent and selective GPR119 agonist with an EC50 of 14 nM, indicated for the treatment of acute and chronic rodent diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 234 | Get Quote |
|
| 5MG | 366 | Get Quote |
|
| 10MG | 520 | Get Quote |
|
| 25MG | 756 | Get Quote |
|
| 50MG | 1021 | Get Quote |
|
| 100MG | 1350 | Get Quote |
|
| 500MG | 2646 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBMS-903452
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-903452 is a potent and selective GPR119 agonist with an EC50 of 14 nM, indicated for the treatment of acute and chronic rodent diabetes.
-
DescriptionBMS-903452 is a potent and selective GPR119 agonist for diabetes research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1339944-47-6
-
Formula Weight513.37
-
Molecular FormulaC21H19Cl2FN4O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(C=C(Cl)C(OC2CCN(CC2)C=3N=CC(Cl)=CN3)=C1)C4=C(F)C=C(S(C)(=O)=O)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wacker DA, et al. Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119. J Med Chem. 2014 Sep 25;57(18):7499-508.?
molnova catalog
related products
-
IBC 293
IBC 293 is selective for GPR109B over niacin receptor GPR109A. IBC 293 is a highly selective agonist for GPR109B, a human orphan G-protein-coupled receptor expressed in adipocytes.
-
FTBMT
FTBMT is a selective GPR52 agonist (EC50: 75 nM) and it also has antipsychotic and procognitive properties.
-
MBX2982
MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.
Cart
sales@molnova.com